{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:41:58Z","timestamp":1790671318973,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Progetti di Rilevante Interesse Nazionale (PRIN), and Bando 2017, protocollo 2017XZMBYX"],"award-info":[{"award-number":["Progetti di Rilevante Interesse Nazionale (PRIN), and Bando 2017, protocollo 2017XZMBYX"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00684","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T10:49:40Z","timestamp":1589366980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes"],"prefix":"10.3389","volume":"11","author":[{"given":"Pietro Enea","family":"Lazzerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Bertolozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Acampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pieragnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"El-Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Laghi-Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Leopoldo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/jc.2016-1877","article-title":"Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration","volume":"101","author":"Abehsira","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/cvr\/cvz020","article-title":"Cardiac arrhythmia considerations of hormone cancer therapies","volume":"115","author":"Barber","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-5347(05)64625-3","article-title":"A clinical study of 22.5 mg. La-2550: A new subcutaneous depot delivery system for leuprolide acetate for the treatment of prostate cancer","volume":"168","author":"Chu","year":"2002","journal-title":"J. Urol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.549071","article-title":"KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome","volume":"112","author":"Crotti","year":"2005","journal-title":"Circulation."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/anec.12481","article-title":"Congenital Long QT syndrome and torsade de pointes","volume":"22","author":"El-Sherif","year":"2017","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/pace.13296","article-title":"Acquired long QT syndrome and torsade de pointes","volume":"41","author":"El-Sherif","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/js.2018-00039","article-title":"Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer","volume":"2","author":"Gagliano-Juc\u00e1","year":"2018","journal-title":"J. Endocr. Soc"},{"key":"B9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1536\/ihj.18-127","article-title":"Medical Castration is a Rare but Possible Trigger of Torsade de Pointes and Ventricular Fibrillation","volume":"60","author":"Hasegawa","year":"2019","journal-title":"Int. Heart J."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"Eur. Heart J."},{"key":"B11","first-page":"124","article-title":"Life threatening torsades de pointes due to abiraterone-induced hypokaelemia in a patient with metastatic prostate cancer","volume":"129","author":"Khan","year":"2016","journal-title":"N Z Med. J."},{"key":"B12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/2047487312467903","article-title":"Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: the Rotterdam Study","volume":"21","author":"Krijthe","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"B14","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1136\/heartjnl-2016-311079","article-title":"Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes","volume":"103","author":"Lazzerini","year":"2017","journal-title":"Heart."},{"key":"B16","doi-asserted-by":"crossref","first-page":"e010595","DOI":"10.1161\/JAHA.118.010595","article-title":"Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies","volume":"7","author":"Lazzerini","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41577-018-0098-z","article-title":"Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies","volume":"19","author":"Lazzerini","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1060028014555362","article-title":"Abiraterone acetate-induced life-threatening torsade de pointes","volume":"49","author":"Rodieux","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"B19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pharmthera.2016.07.005","article-title":"Influence of steroid hormones on ventricular repolarization","volume":"167","author":"Salem","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.118.034282","article-title":"Hypogonadism as a Reversible Cause of Torsades de Pointes in Men","volume":"138","author":"Salem","year":"2018","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.119.040162","article-title":"Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes","volume":"140","author":"Salem","year":"2019","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.acvd.2019.06.008","article-title":"Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study","volume":"112","author":"Salem","year":"2019","journal-title":"Arch. Cardiovasc. Dis."},{"key":"B23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.juro.2010.08.012","article-title":"Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer","volume":"184","author":"Smith","year":"2010","journal-title":"J. Urol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00280-012-1916-9","article-title":"Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer","volume":"70","author":"Tolcher","year":"2012","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T10:49:47Z","timestamp":1589366987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":24,"alternative-id":["10.3389\/fphar.2020.00684"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00684","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"article-number":"684"}}